Equities
  • Price (CHF)3.71
  • Today's Change-0.632 / -14.57%
  • Shares traded600.00
  • 1 Year change--
  • Beta2.1493
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

  • Revenue in USD (TTM)2.53bn
  • Net income in USD-223.59m
  • Incorporated2008
  • Employees5.50k
  • Location
    Teladoc Health Inc155 E 44TH STREET, SUITE 1700NEW YORK 10017United StatesUSA
  • Phone+1 (203) 635-2002
  • Fax+1 (302) 636-5454
  • Websitehttps://www.teladochealth.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TDOC:NYQ since
announced
Transaction
value
Telecare Australia Pty LtdDeal completed08 Aug 202508 Aug 2025Deal completed-27.91%--
Uplift Health Technologies IncDeal completed30 Apr 202530 Apr 2025Deal completed-31.65%45.00m
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.